Tolion Brain Coach is an AI-powered app that supports brain health with features like personalized risk insights, Garmin wearables integration, a weekly brain health planner, progress dashboards, in-app conversational guidance, and a Brain Age score derived from lifestyle, genetics, and biomarkers.

Tolion aims to broaden its ecosystem in 2026, pursuing interoperability enhancements and wider platform collaborations to advance preventive brain health globally.

To raise awareness, Tolion will host webinars for high-risk groups on brain health and dementia prevention, with registration through Tolion Brain Coach Webinar links.

The company provided media and investor contact information and included multiple assets and links to product pages and webinars.

Market and investor interest in DaVita and healthcare tech developments is noted as context for Tolion's efforts.

Tolion founder Martin Tolar commended Moore for strategic and product analysis contributions and guidance since early collaboration.

DaVita HealthCare Partners Inc. news is referenced, including Q3 2025 earnings shortfall and revenue miss; UBS maintained a Buy rating with a $186 target, though 2026 guidance was not provided.

Tolion Health AI appointed Gregory J. Moore, MD, PhD, a former Microsoft and Google Health executive, to its Board of Directors to strengthen leadership, product development, regulatory readiness, and global expansion.

Dr. Moore's strategic priorities include regulatory and quality oversight, data security, advancing Tolion Brain Age, and expanding international partnerships, especially in the U.S., Europe, and Japan.

Moore’s addition aims to merge clinical expertise with advanced technology to scale Tolion’s preventive brain health efforts globally.

Upcoming initiatives include global expansion across the US, Europe, and Japan, regulatory and quality oversight, enhanced data security, expansion of partnerships with laboratories and health plans, and webinars for high-risk groups.

Tolion is positioned as an AI-first platform for early prevention in cognitive decline, targeting global growth, regulatory readiness, privacy, and security while delivering evidence-based guidance.